Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Arndt Vogel(Medizinische Hochschule Hannover), Andrés Cervantes(Universitat de València), Ian Chau(Royal Marsden Hospital), Bruno Daniele(Azienda Ospedaliera G.Rummo), Josep M. Llovet(Institució Catalana de Recerca i Estudis Avançats), Tim Meyer(The Royal Free Hospital), J -C Nault(Hôpital Jean-Verdier), Ulf P. Neumann(RWTH Aachen University), Jens Ricke(Ludwig-Maximilians-Universität München), Bruno Sangro(Centro de Investigación Biomédica en Red), Peter Schirmacher(Heidelberg University), Chris Verslype(Universitair Ziekenhuis Leuven), Francis Zech(University of Basel), Dirk Arnold(Asklepios Klinik Altona), Erika Martinelli(University of Campania "Luigi Vanvitelli")
Cited by 1,061
Abstract
Related Papers
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit et al.|International Journal of Cancer|2014|29k
Sorafenib in Advanced Hepatocellular Carcinoma
Josep M. Llovet, Sergio Ricci, Vincenzo Mazzaferro et al.|New England Journal of Medicine|2008|12.9k